Welcome to the Asia Pacific HIV Clinical Forum website!
The 1st Asia Pacific HIV Clinical Forum on Integrase Inhibitors will be held on 31 May & 1 June, 2017 in Hong Kong, just prior to our 2nd Asian Pacific AIDS & Co-Infections Conference (APACC).
This program is an abstract-driven scientific & educational program dedicated to the integration of science and clinical practice focusing on Integrase Inhibitors.
By joining us, you will be updated on the latest developments related to Integrase, and will be provided with a platform to share your clinical experience. The program will include plenary lectures, Q&A and debate, stimulating interaction in order to bridge the knowledge gap between experts and the HIV treatment community.
This Forum offers a unique platform for discussion on the clinical utility of Integrase Inhibitors in daily practice. After your participation in the meeting, you will be able to:
identify and manage patients who would be eligible for induction-maintenance therapy;
recognize potential drug interactions and, based on this knowledge, develop treatment strategies that could prevent these interactions;
design treatment strategies for different patient populations;
describe and identify the various factors that influence the use of long acting antivirals.
Who should attend?
If you are doing research on or have clinical experience with Integrase Inhibitors or if you are interested in learning more about using Integrase Inhibitors in daily practice, please join us on 31 May and 1 June, 2017 in Hong Kong. Location: tba.
We look forward to welcoming you to the meeting in Hong Kong!
The Program Chairs
Charles Boucher, MD, PhD
Patrick Chung-Ki Li, MBBS, FHKCP, FHKAM, FRCP
Jonathan Schapiro, MD
Wednesday 31 May
11.00h Registration & Welcome Coffee
11.30h Welcome, Introductions and Goals
11.45h State of the Art Lecture: Understanding Viral Suppression
12.15h State of the Art Lecture
12.45h Q&A and Discussion
14.15h State of the Art Lecture
14.45h State of the Art Lecture: Clinical Experience with Integrase Inhibitors
15-15h – 16.00h Abstract Presentations
16.00h COFFEE BREAK
16.30h State of the Art Lecture: Social Considerations in HIV Treatment Decisions in Asian Population
17.00h State of the Art Lecture: Treatment Considerations in HIV Infected Children and Women in Asia
17.30h-18.00h Abstract Presentations
18.45h Clinical Case presentations
19.45h End of Program
20.00h Networking Dinner
Thursday 1 June
8.30h State of the Art Lecture: Induction-Maintenance Therapy: Who, When, How?
9.00h 2nd Line Treatment Options in Resource Limited Settings
9.30h Abstract Presentations
10.00h Clinical Case presentation
10.20h Q&A and Discussion
10.55h Closure of workshop
Don’t miss out and register for the exciting 1st Asia Pacific Forum Meeting in Hong Kong! Use the “Register Here” button at the bottom of this page.
REGISTRATION IS LIMITED!
– We strongly suggest that you register early to ensure your spot at the meeting, as registration will no longer be possible when the capacity of the venue is reached.
– Submission of your online registration does not guarantee that your registration has been accepted. Your registration is final when a confirmation of your registration has been sent.
Unfortunately, abstract submission is now closed.
The Abstract Review Committee is currently reviewing all submitted abstracts and will contact the abstracts within two weeks of closing date (3 March).
If you have any questions, please do not hesitate to contact us at email@example.com.
Abstract submission is CLOSED
Conference Participation Grants (CPGs)
Grant application is CLOSED.
Unfortunately, the CPG portal is now closed. The Grant Review Committee is currently reviewing the applications and will be informing the applicants within two weeks.
Should you have any questions, please do not hesitate to contact Ms. Naima Calor at firstname.lastname@example.org.
Financial backing from the corporate community will help us deliver an impactful and essential meeting experience. This collaboration plays a vital for both the organizational as well as the scientific success of the program.
Your financial support will help advance the field significantly by providing healthcare professionals with a platform to present findings, discuss conclusions, and create strategies for the future.
Show your commitment to the cause and get in touch with us for a tailored support package, please contact Alice Posthumus-Plantinga at email@example.com or call +31 6 224 82 179.
The 1st Asia Pacific HIV Forum meeting : Integrase Inhibitors is generously supported by an unrestricted educational grant from ViiV Healthcare.
Support of Asia Pacific HIV Clinical Forum offers a unique opportunity to associate your company with this premier meeting. For information regarding support opportunities, please contact Ms. Lena Hartandi-Niesen at firstname.lastname@example.org.
The Asia Pacific HIV Clinical Forum is endorsed by the following organizations. Their support and collaboration play a key role to this meeting’s success and we are proud and honoured to call each and every one of them partners. Members of the below organizations receive a 25% discount on registration fees. Get in touch with us if you want your organization to be part of Asia Pacific HIV Clinical Forum at email@example.com.
Accreditation will be applied for at the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS).
Accreditation will also be applied for at the Hong Kong Academy of Medicine (HKAM), an independent institution in Hong Kong with the statutory power to organise, monitor, assess and accredit all medical specialist training and to oversee the provision of continuing medical education.
The meeting will take place just prior to the APACC 2017 Conference.